ReviewCurrent opinion in endocrinology, diabetes, and obesity2018

Diabetes pathogenic mechanisms and potential new therapies based upon a novel target called TXNIP.

Lance Thielen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.